These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30540223)

  • 1. An update on the clinical consequences of polypharmacy in older adults: a narrative review.
    Wastesson JW; Morin L; Tan ECK; Johnell K
    Expert Opin Drug Saf; 2018 Dec; 17(12):1185-1196. PubMed ID: 30540223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.
    Pazan F; Wehling M
    Eur Geriatr Med; 2021 Jun; 12(3):443-452. PubMed ID: 33694123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical consequences of polypharmacy in elderly.
    Maher RL; Hanlon J; Hajjar ER
    Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy in multimorbid older adults: protocol for a systematic review.
    Sirois C; Laroche ML; Guénette L; Kröger E; Cooper D; Émond V
    Syst Rev; 2017 May; 6(1):104. PubMed ID: 28526062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of prevalence, determinants and health outcomes of polypharmacy.
    Khezrian M; McNeil CJ; Murray AD; Myint PK
    Ther Adv Drug Saf; 2020; 11():2042098620933741. PubMed ID: 32587680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy in elderly patients.
    Hajjar ER; Cafiero AC; Hanlon JT
    Am J Geriatr Pharmacother; 2007 Dec; 5(4):345-51. PubMed ID: 18179993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication use and functional status decline in older adults: a narrative review.
    Peron EP; Gray SL; Hanlon JT
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):378-91. PubMed ID: 22057096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.
    Martinez YV; Renom-Guiteras A; Reeves D; Erandie Ediriweera de Silva R; Esmail A; Kunnamo I; Rieckert A; Sommerauer C; Sönnichsen A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):231. PubMed ID: 29047332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews.
    Davies LE; Spiers G; Kingston A; Todd A; Adamson J; Hanratty B
    J Am Med Dir Assoc; 2020 Feb; 21(2):181-187. PubMed ID: 31926797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing drug therapy for older adults: shifting away from problematic polypharmacy.
    Daunt R; Curtin D; O'Mahony D
    Expert Opin Pharmacother; 2024 Jun; 25(9):1199-1208. PubMed ID: 38940370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to improve the appropriate use of polypharmacy for older people.
    Patterson SM; Hughes C; Kerse N; Cardwell CR; Bradley MC
    Cochrane Database Syst Rev; 2012 May; (5):CD008165. PubMed ID: 22592727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in older adults: a narrative review of the literature.
    Zazzara MB; Palmer K; Vetrano DL; Carfì A; Onder G
    Eur Geriatr Med; 2021 Jun; 12(3):463-473. PubMed ID: 33738772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review.
    Nicholson K; Liu W; Fitzpatrick D; Hardacre KA; Roberts S; Salerno J; Stranges S; Fortin M; Mangin D
    Lancet Healthy Longev; 2024 Apr; 5(4):e287-e296. PubMed ID: 38452787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.
    Lee GB; Etherton-Beer C; Hosking SM; Pasco JA; Page AT
    Ther Adv Drug Saf; 2022; 13():20420986221100117. PubMed ID: 35814333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multiple antipsychotic use and associated adverse effects in Australians with mental illness.
    Westaway K; Sluggett JK; Alderman C; Procter N; Roughead E
    Int J Evid Based Healthc; 2016 Sep; 14(3):104-12. PubMed ID: 27213238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.